Rocket Pharmaceuticals, Inc.
RCKT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $76 | $33 | $50 | $164 |
| Short-Term Investments | $147 | $239 | $268 | $209 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $6 | $6 | $6 |
| Total Curr. Assets | $228 | $277 | $324 | $378 |
| Property Plant & Equip (Net) | $74 | $78 | $80 | $83 |
| Goodwill | $39 | $39 | $39 | $39 |
| Intangibles | $25 | $25 | $25 | $25 |
| Long-Term Investments | $1 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $2 | $2 | $2 |
| Total NC Assets | $140 | $144 | $147 | $150 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $368 | $421 | $471 | $528 |
| Liabilities | – | – | – | – |
| Payables | $0 | $2 | $3 | $2 |
| Short-Term Debt | $3 | $3 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $28 | $39 | $29 | $36 |
| Total Curr. Liab. | $31 | $43 | $35 | $41 |
| LT Debt | $22 | $22 | $22 | $23 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $23 | $23 | $24 | $24 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $22 | $25 | $25 | $25 |
| Total Liabilities | $54 | $67 | $59 | $64 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$1,399 | -$1,348 | -$1,279 | -$1,218 |
| AOCI | -$0 | -$0 | -$0 | $0 |
| Other Equity | $1,711 | $1,702 | $1,691 | $1,680 |
| Total Equity | $314 | $354 | $412 | $463 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $368 | $421 | $471 | $528 |
| Net Debt | -$51 | -$8 | -$24 | -$138 |